Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates

分组1 - Elanco Animal Health reported quarterly earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.11 per share, but down from $0.14 per share a year ago, resulting in an earnings surprise of +16.07% [1] - The company achieved revenues of $1.14 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.72% and increasing from $1.02 billion year-over-year [2] - Elanco Animal Health has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has increased approximately 9.4% since the beginning of the year, contrasting with a slight decline of 0.1% in the S&P 500 [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.36 for the coming quarter and $1.02 for the current fiscal year [7] - The Zacks Industry Rank places the Medical - Outpatient and Home Healthcare sector in the bottom 42% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]